Immix Biopharma, Inc. IMMX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$34.94M-67.1% | -$29.4M-35.5% | -$23.56M-6.9% | -$23.13M-20.2% | -$20.91M-13.5% | ||
| $299.17K+339% | $245.75K+646% | $214.24K+1,290% | $122.7K+981% | $68.08K+754% | ||
| $2.15M-27.0% | $2.44M-19.2% | $2.58M-23.4% | $2.84M-15.7% | $2.95M-7.3% | ||
| -$32.07M-158% | -$23.93M-64.0% | -$14.38M+9.0% | -$12.51M+15.8% | -$12.45M+5.0% | ||
| $697.7K-26.1% | $732.93K-37.8% | $1.07M+57.2% | $974.04K— | $943.48K— | ||
| -$11.95M-1,166% | -$7.21M-513% | -$1.07M-57.2% | -$974.04K— | -$943.48K— | ||
| —— | —— | —— | —— | —— | ||
| $63.33M— | $76.25M— | —— | —— | —— | ||
| -$32.77M-145% | -$24.66M-56.4% | -$15.45M+6.2% | -$13.48M— | -$13.4M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Immix Biopharma, Inc. generate?
- Immix Biopharma, Inc. (IMMX) generated -$32.1M in operating cash flow over the trailing twelve months.
- What is Immix Biopharma, Inc.'s free cash flow?
- After $697.7K of capital expenditures, Immix Biopharma, Inc.'s free cash flow was -$32.8M over the trailing twelve months, down 144.6% year over year.
- Where does Immix Biopharma, Inc.'s cash flow data come from?
- Every line is extracted from Immix Biopharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.